Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Mesna
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mesna 400mg tablets
0801000T0AAACAC
|
Mesna (Cancer) | Mesna | Malignant Disease and Immunosuppression | 2 |
|
Mesna 1g/10ml solution for injection ampoules
0801000T0AAABAB
|
Mesna (Cancer) | Mesna | Malignant Disease and Immunosuppression | No data available |
|
Mesna 400mg/4ml solution for injection ampoules
0801000T0AAAAAA
|
Mesna (Cancer) | Mesna | Malignant Disease and Immunosuppression | No data available |
|
Mesna 40mg/5ml oral solution
0801000T0AAAEAE
|
Mesna (Cancer) | Mesna | Malignant Disease and Immunosuppression | No data available |
|
Mesna 600mg tablets
0801000T0AAADAD
|
Mesna (Cancer) | Mesna | Malignant Disease and Immunosuppression | No data available |
|
Uromitexan 1g/10ml solution for injection ampoules
0801000T0BBABAB
|
Uromitexan | Mesna | Malignant Disease and Immunosuppression | No data available |
|
Uromitexan 400mg tablets
0801000T0BBADAC
|
Uromitexan | Mesna | Malignant Disease and Immunosuppression | No data available |
|
Uromitexan 400mg/4ml solution for injection ampoules
0801000T0BBAAAA
|
Uromitexan | Mesna | Malignant Disease and Immunosuppression | No data available |
|
Uromitexan 600mg tablets
0801000T0BBAEAD
|
Uromitexan | Mesna | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.